Short answer: yes, photobiomodulation (PBM) has been scientifically studied and positive results have been found for some applications. However, the evidence is not equally strong for every application, and a research result for one protocol does not automatically prove that every consumer device has the same effect.
For quick answers to frequently asked questions about how it works, 660nm, 850nm, dosage, safety, and evidence: check out the Red Light Therapy FAQ.
What does the broader research say?
An umbrella review from 2025 pooled 15 meta-analyses with 204 randomized studies and more than 9,000 participants. Moderate certainty was found for some outcomes, including hair density in androgenetic alopecia. For many other outcomes, the certainty was low or very low.
For the skin
A randomized, sham-controlled study from 2025 investigated a 660nm LED mask for facial rejuvenation. This is relevant evidence for the studied protocol, but it does not mean that every 660nm mask will yield the same outcome.
For hair
For androgenetic alopecia, PBM is a relatively well-researched area of application. A meta-analysis found higher hair density with PBM than with control, while a later umbrella review also reported moderate certainty for this specific result.
How do you evaluate a claim?
- Which application was studied?
- Which wavelength(s) were used?
- Which dose and treatment time were studied?
- Was there a control group or sham treatment?
- How large was the study?
- Does the consumer device sufficiently match the studied protocol?
Conclusion
Red light therapy is not an unproven hype, but also not a universal guarantee. The strongest communication always links a claim to the specific application, the protocol, and the quality of the evidence.